|
Protein Ubiquitination Pathway
|
16.80
|
148/274 (54%)
|
|
Glucocorticoid Receptor Signaling
|
16.80
|
148/295 (50%)
|
|
Oxidative Phosphorylation
|
15.00
|
92/159 (58%)
|
|
Mitochondrial Dysfunction
|
14.00
|
86/175 (49%)
|
|
CD28 Signaling in T Helper Cells
|
13.70
|
77/132 (58%)
|
|
Regulation of eIF4 and p70S6K Signaling
|
11.90
|
69/132 (52%)
|
|
Role of NFAT in Regulation of the Immune Response
|
10.70
|
97/200 (49%)
|
|
EIF2 Signaling
|
10.60
|
57/101 (56%)
|
|
PI3K/AKT Signaling
|
10.50
|
73/140 (52%)
|
|
iCOS-iCOSL Signaling in T Helper Cells
|
10.50
|
67/122 (55%)
|
|
B Cell Receptor Signaling
|
10.10
|
83/156 (53%)
|
|
Regulation of IL-2 Expression in Lymphocytes
|
9.70
|
53/89 (60%)
|
|
Integrin Signaling
|
9.48
|
104/209 (50%)
|
|
PKCθ Signaling in T Lymphocytes
|
8.93
|
68/142 (48%)
|
|
Hypoxia Signaling in the Cardiovascular System
|
8.93
|
46/68 (68%)
|
|
CTLA4 Signaling in Cytotoxic T Lymphocytes
|
8.52
|
57/98 (58%)
|
|
mTOR Signaling
|
8.51
|
79/162 (49%)
|
|
T Cell Receptor Signaling
|
8.43
|
59/109 (54%)
|
|
Type I Diabetes Mellitus Signaling
|
8.32
|
64/121 (53%)
|
|
Production of Nitric Oxide and ROS in Macrophages
|
8.32
|
83/187 (44%)
|
|
Ubiquinone Biosynthesis
|
8.05
|
45/112 (40%)
|
|
Molecular Mechanisms of Cancer
|
7.64
|
152/377 (40%)
|
|
Estrogen Receptor Signaling
|
7.54
|
70/136 (51%)
|
|
Antigen Presentation Pathway
|
7.20
|
30/43 (70%)
|
|
Apoptosis Signaling
|
7.19
|
53/96 (55%)
|
|
G2/M DNA Damage Checkpoint Regulation
|
7.19
|
32/49 (65%)
|
|
Prostate Cancer Signaling
|
6.96
|
49/97 (51%)
|
|
Phospholipase C Signaling
|
6.79
|
109/260 (42%)
|
|
Huntington’s Disease Signaling
|
6.78
|
104/238 (44%)
|
|
Chronic Myeloid Leukemia Signaling
|
6.65
|
54/105 (51%)
|
|
Pancreatic Adenocarcinoma Signaling
|
6.61
|
59/119 (50%)
|
|
IL-8 Signaling
|
6.60
|
86/193 (45%)
|
|
PI3K Signaling in B Lymphocytes
|
6.50
|
69/143 (48%)
|
|
Breast Cancer Regulation by Stathmin1
|
6.49
|
93/208 (45%)
|
|
IL-2 Signaling
|
6.31
|
35/58 (60%)
|
|
NF-κ B Activation by Viruses
|
6.26
|
44/82 (54%)
|
|
IL-15 Signaling
|
6.23
|
39/68 (57%)
|
|
T Helper Cell Differentiation
|
6.15
|
42/72 (58%)
|
|
TREM1 Signaling
|
6.05
|
35/66 (53%)
|
|
Fcγ Receptor-mediated Phagocytosis in Macrophages
|
5.98
|
52/102 (51%)
|
|
Pyrimidine Metabolism
|
5.85
|
70/213 (33%)
|
|
GM-CSF Signaling
|
5.69
|
38/67 (57%)
|
|
Induction of Apoptosis by HIV1
|
5.64
|
37/66 (56%)
|
|
Dendritic Cell Maturation
|
5.64
|
78/188 (41%)
|
|
NRF2-mediated Oxidative Stress Response
|
5.63
|
86/193 (45%)
|
|
Purine Metabolism
|
5.56
|
117/391 (30%)
|
|
fMLP Signaling in Neutrophils
|
5.50
|
57/128 (45%)
|
|
JAK/Stat Signaling
|
5.42
|
37/64 (58%)
|
|
HMGB1 Signaling
|
5.40
|
51/100 (51%)
|
|
IL-4 Signaling
|
5.40
|
40/73 (55%)
|
